Mizuho Analysts Give Atara Biotherapeutics (NASDAQ:ATRA) a $43.00 Price Target

Retrieved on: 2019-09-28 18:41:15

Tags for this article:

Click the tags to see associated articles and topics

Mizuho Analysts Give Atara Biotherapeutics (NASDAQ:ATRA) a $43.00 Price Target. View article details on hiswai:

Excerpt

<div><b>Baupost Group</b> LLC MA lifted its stake in Atara Biotherapeutics by 9.7% in the second quarter. <b>Baupost Group</b> LLC MA now owns 7,000,000 shares of ...</div>

Article found on:

View Original Article